The recent explosion of scientific knowledge and technological progress has led to the
discovery of a large array of circulating molecules commonly referred to as biomarkers …

Heart failure (HF) represents a significant global health challenge, characterized by high
morbidity and mortality rates, and imposes considerable burdens on healthcare systems and …

Abstract Purpose of Review Heart failure (HF) is one of the leading causes of cardiac
morbidity and mortality around the world. Our evolving understanding of the cellular and …

Biomarker testing in patients with heart failure (HF) is rapidly expanding. With high-quality
research indicating its diagnostic and prognostic capabilities, biomarkers are excellent …

Acute heart failure (AHF) episodes are marked by high rates of morbidity and mortality
during the episode and minimal advancements in its care. Multiple biomarker monitoring is …

Heart failure (HF) is a complex syndrome with an enormous societal burden in terms of cost,
morbidity, and mortality. Natriuretic peptide testing is now widely used to support diagnosis …

Despite the enhanced knowledge of the pathophysiology of heart failure (HF), it still remains
a serious syndrome with substantial morbidity, mortality, and frequent hospitalizations …

The last decade has seen exciting advances in the field of biomarkers used in managing
patients with heart failure (HF). Biomarker research has broadened our knowledge base …

The spectrum of heart failure biomarkers and their potential clinical applications continues to
grow. Ongoing research on multimarker strategies will likely identify biomarker combinations …

Biological markers have served for diagnosis, risk stratification and guided therapy of heart
failure (HF). Our knowledge regarding abilities of biomarkers to relate to several pathways of …